FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387116121> ?p ?o ?g. }

• W4387116121 abstract "The implementation of an Enhanced Recovery After Surgery (ERAS) protocol in patients with locally advanced rectal cancer (LARC) and locally recurrent rectal cancer (LRRC) has been deemed unfeasible until now because of the heterogeneity of this disease and low caseloads. Since evidence and experience with ERAS principles in colorectal cancer care are increasing, a modified ERAS protocol for this specific group has been developed. The aim of this study is to evaluate the implementation of a tailored ERAS protocol for patients with LARC or LRRC, requiring beyond total mesorectal excision (bTME) surgery.Patients who underwent a bTME for LARC or LRRC between October 2021 and December 2022 were prospectively studied. All patients were treated in accordance with the ERAS LARRC protocol, which consisted of 39 ERAS care elements specifically developed for patients with LARC and LRRC. One of the most important adaptations of this protocol was the anaesthesia procedure, which involved the use of total intravenous anaesthesia with intravenous (iv) lidocaine, iv methadone, and iv ketamine instead of epidural anaesthesia. The outcomes showed compliance with ERAS care elements, complications, length of stay, and functional recovery. A follow-up was performed at 30 and 90 days post-surgery.Seventy-two patients were selected, all of whom underwent bTME for either LARC (54.2%) or LRRC (45.8%). Total compliance with the adjusted ERAS protocol was 73.6%. Major complications were present in 12 patients (16.7%), and the median length of hospital stay was 9 days (IQR 6.0-14.0). Patients who received multimodal anaesthesia (75.0%) stayed in the hospital for a median of 7.0 days (IQR 6.8-15.5). These patients received fewer opioids on the first three postoperative days than patients who received epidural analgesia (p < 0.001).The implementation of the ERAS LARRC protocol seemed successful according to its compliance rate of >70%. Its complication rate was substantially reduced in comparison with the literature. Multimodal anaesthesia is feasible in beyond TME surgery with promising effects on recovery after surgery." @default.
• W4387116121 created "2023-09-29" @default.
• W4387116121 creator A5013432555 @default.
• W4387116121 creator A5020134753 @default.
• W4387116121 creator A5023049337 @default.
• W4387116121 creator A5029445544 @default.
• W4387116121 creator A5029652744 @default.
• W4387116121 creator A5037535575 @default.
• W4387116121 creator A5047180575 @default.
• W4387116121 creator A5073552513 @default.
• W4387116121 creator A5080105484 @default.
• W4387116121 creator A5092402592 @default.
• W4387116121 creator A5092957109 @default.
• W4387116121 creator A5092957110 @default.
• W4387116121 date "2023-09-12" @default.
• W4387116121 modified "2023-10-17" @default.
• W4387116121 title "Implementation of an Enhanced Recovery after Surgery Protocol in Advanced and Recurrent Rectal Cancer Patients after beyond Total Mesorectal Excision Surgery: A Feasibility Study." @default.
• W4387116121 cites W1816870656 @default.
• W4387116121 cites W1830155125 @default.
• W4387116121 cites W1830195387 @default.
• W4387116121 cites W19145836 @default.
• W4387116121 cites W1980747032 @default.
• W4387116121 cites W1984242781 @default.
• W4387116121 cites W2004973581 @default.
• W4387116121 cites W2021099858 @default.
• W4387116121 cites W2052971221 @default.
• W4387116121 cites W2056083761 @default.
• W4387116121 cites W2067516672 @default.
• W4387116121 cites W2074899025 @default.
• W4387116121 cites W2075618546 @default.
• W4387116121 cites W2096998881 @default.
• W4387116121 cites W2111671951 @default.
• W4387116121 cites W2115757854 @default.
• W4387116121 cites W2123710375 @default.
• W4387116121 cites W2125173086 @default.
• W4387116121 cites W2145110949 @default.
• W4387116121 cites W2159157136 @default.
• W4387116121 cites W2801510783 @default.
• W4387116121 cites W2885648137 @default.
• W4387116121 cites W2915149968 @default.
• W4387116121 cites W2920713811 @default.
• W4387116121 cites W2953596390 @default.
• W4387116121 cites W2998868990 @default.
• W4387116121 cites W3013558567 @default.
• W4387116121 cites W3048639739 @default.
• W4387116121 cites W3124743078 @default.
• W4387116121 cites W3126674121 @default.
• W4387116121 cites W3132102546 @default.
• W4387116121 cites W3159070759 @default.
• W4387116121 cites W3168010925 @default.
• W4387116121 cites W3168130471 @default.
• W4387116121 cites W3173272455 @default.
• W4387116121 cites W3185929041 @default.
• W4387116121 cites W3212586870 @default.
• W4387116121 cites W3217305101 @default.
• W4387116121 cites W4200272504 @default.
• W4387116121 cites W4211085362 @default.
• W4387116121 cites W4211191397 @default.
• W4387116121 cites W4211229530 @default.
• W4387116121 cites W4241598067 @default.
• W4387116121 cites W4251569536 @default.
• W4387116121 cites W4253893565 @default.
• W4387116121 cites W4281608558 @default.
• W4387116121 cites W4294712956 @default.
• W4387116121 cites W4317394637 @default.
• W4387116121 cites W4323067045 @default.
• W4387116121 doi "https://doi.org/10.3390/cancers15184523" @default.
• W4387116121 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37760492" @default.
• W4387116121 hasPublicationYear "2023" @default.
• W4387116121 type Work @default.
• W4387116121 citedByCount "0" @default.
• W4387116121 crossrefType "journal-article" @default.
• W4387116121 hasAuthorship W4387116121A5013432555 @default.
• W4387116121 hasAuthorship W4387116121A5020134753 @default.
• W4387116121 hasAuthorship W4387116121A5023049337 @default.
• W4387116121 hasAuthorship W4387116121A5029445544 @default.
• W4387116121 hasAuthorship W4387116121A5029652744 @default.
• W4387116121 hasAuthorship W4387116121A5037535575 @default.
• W4387116121 hasAuthorship W4387116121A5047180575 @default.
• W4387116121 hasAuthorship W4387116121A5073552513 @default.
• W4387116121 hasAuthorship W4387116121A5080105484 @default.
• W4387116121 hasAuthorship W4387116121A5092402592 @default.
• W4387116121 hasAuthorship W4387116121A5092957109 @default.
• W4387116121 hasAuthorship W4387116121A5092957110 @default.
• W4387116121 hasConcept C121608353 @default.
• W4387116121 hasConcept C126322002 @default.
• W4387116121 hasConcept C141071460 @default.
• W4387116121 hasConcept C2776078045 @default.
• W4387116121 hasConcept C2777201421 @default.
• W4387116121 hasConcept C2780149897 @default.
• W4387116121 hasConcept C526805850 @default.
• W4387116121 hasConcept C71924100 @default.
• W4387116121 hasConceptScore W4387116121C121608353 @default.
• W4387116121 hasConceptScore W4387116121C126322002 @default.
• W4387116121 hasConceptScore W4387116121C141071460 @default.
• W4387116121 hasConceptScore W4387116121C2776078045 @default.
• W4387116121 hasConceptScore W4387116121C2777201421 @default.
• W4387116121 hasConceptScore W4387116121C2780149897 @default.
• W4387116121 hasConceptScore W4387116121C526805850 @default.
• W4387116121 hasConceptScore W4387116121C71924100 @default.

• next